Clinic
Cedar Riverside People's Center
Cedar Riverside People's Center was paid $15.30M by Medicaid between Jan 2018 and Dec 2024, across 95 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 47% of everything it billed.
33Billing provider infoCEDAR RIVERSIDE PEOPLE'S CENTER
MINNEAPOLIS, MN 55454
MINNEAPOLIS, MN 55454
33aNPI1548340813assigned 10/17/2006
33bProvider typeCommunity Health Clinic/Center
28Total paid$15.30M
24GClaims222,687
24DCodes billed95
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Community Health Clinic/Center providers in Minnesota
Rank by total paid#1 of 13
Median peer was paid$227K
This provider vs. median67×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 54,197 | $2.31M | |
| 2019 | 44,003 | $2.44M | |
| 2020 | 25,993 | $2.67M | |
| 2021 | 33,802 | $2.44M | |
| 2022 | 27,389 | $2.30M | |
| 2023 | 22,781 | $1.69M | |
| 2024incomplete | 14,522 | $1.44M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 47% | 49,879 | 40,812 | $7.25M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 18% | 19,910 | 17,434 | $2.77M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 9.5% | 9,043 | 7,969 | $1.46M |
| G0467 | Community health center visit, returning patientFederally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 6.8% | 10,347 | 8,050 | $1.04M |
| X5622 | 5.9% | 7,793 | 5,907 | $898K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 3.8% | 2,893 | 2,740 | $578K |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 3.1% | 3,032 | 2,001 | $474K |
| 90837 | Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient | 1.9% | 1,478 | 811 | $295K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.2% | 1,124 | 1,049 | $181K |
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | <1% | 2,277 | 1,681 | $88K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 2,161 | 1,625 | $43K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 190 | 174 | $40K |
83 more codes
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 253 | $40K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 1,546 | $34K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 137 | $26K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 1,138 | $21K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | <1% | 2,489 | $19K |
| 96156 | <1% | 132 | $17K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 59 | $7K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 520 | $5K |
| 99201 | <1% | 24 | $5K | |
| G0466 | Community health center visit, new patient | <1% | 20 | $5K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 335 | $5K |
| T1013 | Sign language or oral interpretive services, per 15 minutes | <1% | 396 | $2K |
| 36415 | Collection of venous blood by venipuncture | <1% | 15,828 | $2K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 6,539 | $1K |
| 99188 | <1% | 3,110 | $898.72 | |
| 96150 | <1% | 64 | $865.24 | |
| 82962 | <1% | 7,829 | $541.75 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 9,717 | $492.51 |
| 91322 | <1% | 17 | $431.92 | |
| 90480 | <1% | 83 | $145.60 | |
| 90662 | <1% | 158 | $89.46 | |
| 90686 | <1% | 4,434 | $83.05 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,181 | $55.00 |
| 0134A | <1% | 45 | $42.10 | |
| 0064A | <1% | 349 | $39.79 | |
| 85018 | <1% | 5,813 | $32.45 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 3,614 | $23.70 |
| 81003 | <1% | 3,705 | $22.10 | |
| 87807 | <1% | 48 | $14.41 | |
| 81025 | <1% | 1,929 | $9.66 | |
| 96127 | 0% | 7,266 | $0.00 | |
| 92551 | 0% | 5,639 | $0.00 | |
| 0011A | 0% | 1,394 | $0.00 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 0% | 5,687 | $0.00 |
| 90698 | 0% | 741 | $0.00 | |
| 0111A | 0% | 49 | $0.00 | |
| 36416 | 0% | 1,320 | $0.00 | |
| 90651 | 0% | 125 | $0.00 | |
| 0001A | 0% | 440 | $0.00 | |
| 90744 | 0% | 214 | $0.00 | |
| 0012A | 0% | 1,346 | $0.00 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 0% | 245 | $0.00 |
| 90620 | 0% | 26 | $0.00 | |
| 90716 | 0% | 61 | $0.00 | |
| 90657 | 0% | 133 | $0.00 | |
| 90696 | 0% | 31 | $0.00 | |
| 96161 | 0% | 240 | $0.00 | |
| 90660 | 0% | 327 | $0.00 | |
| 93000 | 0% | 27 | $0.00 | |
| 0072A | 0% | 141 | $0.00 | |
| 90656 | 0% | 18 | $0.00 | |
| 0164A | 0% | 18 | $0.00 | |
| 0052A | 0% | 20 | $0.00 | |
| 90697 | 0% | 18 | $0.00 | |
| 90677 | 0% | 24 | $0.00 | |
| 0031A | 0% | 23 | $0.00 | |
| 92567 | 0% | 16 | $0.00 | |
| 90672 | 0% | 778 | $0.00 | |
| 99173 | 0% | 5,708 | $0.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 743 | $0.00 |
| 90633 | 0% | 567 | $0.00 | |
| 90710 | 0% | 53 | $0.00 | |
| 90670 | 0% | 1,222 | $0.00 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 0% | 661 | $0.00 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 239 | $0.00 |
| 81002 | 0% | 630 | $0.00 | |
| 0071A | 0% | 241 | $0.00 | |
| 90473 | 0% | 1,010 | $0.00 | |
| 0002A | 0% | 392 | $0.00 | |
| 90734 | 0% | 425 | $0.00 | |
| 90681 | 0% | 142 | $0.00 | |
| 80061 | Lipid panel | 0% | 343 | $0.00 |
| 90715 | 0% | 687 | $0.00 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 0% | 159 | $0.00 |
| 90658 | 0% | 979 | $0.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 175 | $0.00 |
| 0121A | 0% | 27 | $0.00 | |
| 90461 | 0% | 82 | $0.00 | |
| 0124A | 0% | 43 | $0.00 | |
| 0004A | 0% | 67 | $0.00 | |
| 90691 | 0% | 14 | $0.00 | |
| 0151A | 0% | 29 | $0.00 | |
| 90655 | 0% | 43 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialROGERS, ANN (CEO)